DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Evoclin (Clindamycin Phosphate Topical) - Published Studies

 
 



Evoclin Related Published Studies

Well-designed clinical trials related to Evoclin (Clindamycin Topical)

Efficacy of clindamycin in reducing pain following tonsillectomy in adults: a double-blind, randomised trial. [2013]

Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. [2013]

A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks. [2012]

Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial. [2011.11]

Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomelanosis: a randomized, doubleblind, placebo-controlled trial. [2011.02]

Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial. [2011]

Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. [2011]

Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomelanosis: a randomized, doubleblind, placebo-controlled trial. [Article in English, Portuguese] [2011]

A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris. [2010.02]

Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris. [2009.05]

Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel. [2009.04]

Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability. [2009.03]

A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring. [2008.08]

Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. [2007.07]

Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. [2007.06]

Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study. [2006.11]

Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. [2006.03]

A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne. [2006]

Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. [2005.09]

Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris. [2005.07]

Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination. [2005.03]

A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. [2005.01]

The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris. [2005.01]

An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. [2005]

Well-designed clinical trials possibly related to Evoclin (Clindamycin Topical)

Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris. [2011.03]

The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial. [2010.08]

Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. [2010.08]

Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. [2010.04]

Comparative efficacy and safety results of two topical combination acne regimens. [2009.07]

Oral isotretinoin is as effective as a combination of oral isotretinoin and topical anti-acne agents in nodulocystic acne. [2008.03]

Pilot investigation of the hydrating effects of topical acne medications. [2007.08]

Clinical and Microbiological Comparisons of Isotretinoin vs. Tetracycline in Acne Vulgaris. [2007]

Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies. [2006.09]

Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial. [2006.03]

Non-surgical periodontal therapy with adjunctive topical doxycycline: a double-masked, randomized, controlled multicenter study. II. Microbiological results. [2005.01]

Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. [2005.01]

Other research related to Evoclin (Clindamycin Topical)

Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne. [2013]

Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study. [2012]

Effect of sequential application of topical adapalene and clindamycin phosphate in the treatment of Japanese patients with acne vulgaris. [2012]

Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. [2011.12]

Topical clindamycin 1% vs. linoleic acid-rich phosphatidylcholine and nicotinamide 4% in the treatment of acne: a multicentre-randomized trial. [2011.10]

Clindamycin 1.2% Tretinoin 0.025% Gel versus Clindamycin Gel Treatment in Acne Patients: A Focus on Fitzpatrick Skin Types. [2011.06]

Effect of sequential application of topical adapalene and clindamycin phosphate in the treatment of Japanese patients with acne vulgaris. [2011.01.22]

Canine periodontal disease control using a clindamycin hydrochloride gel. [2011]

Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. [2010.07]

A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. [2010.01]

A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris. [2010]

Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management. [2009.11]

Topical clindamycin in post-adenotonsillectomy analgesia in children: A double-blind, randomized clinical trial. [2009.10]

The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel. [2009.07]

Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial. [2009.05]

Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. [2009.05]

[Management of acne vulgaris: focus on clindamycin and zinc] [2009.01]

Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study. [2008.11]

Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris. [2008.11]

A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. [2008.01]

Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne. [2008]

Topical clindamycin in the management of acne vulgaris. [2007.10]

Clindamycin and taste disorders. [2007.10]

Adapalene pretreatment increases follicular penetration of clindamycin: in vitro and in vivo studies. [2007.09]

Enhancement of the skin permeation of clindamycin phosphate by Aerosol OT/1-butanol microemulsions. [2007.08]

Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. [2007.07.13]

Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris. [2007.06]

A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. [2007.03]

The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid. [2006.02]

Other possibly related research studies

Clinical inquiries. What is the best treatment for mild to moderate acne? [2006.11]

Systemic antibiotic therapy of acne vulgaris. [2006.10]

Improvement of cystic fibrosis during treatment with isotretinoin. [2006.09]

The effect of simulated solar UV irradiation on tretinoin in tretinoin gel microsphere 0.1% and tretinoin gel 0.025%. [2006.05]

[Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid] [2006.04]

Photodynamic therapy for perioral dermatitis. [2006.02]

Topical therapies for rosacea. [2006.01]

Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment. [2005]

Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children. [2005.09]

Antibiotic treatment of acne may be associated with upper respiratory tract infections. [2005.09]

The role of the vehicle in combination acne therapy. [2005.08]

[Rosacea. Clinical features, pathogenesis and therapy] [2005.09]

Treatment of acne with topical antibiotics: lessons from clinical studies. [2005.08]

Bacterial vaginosis--a disturbed bacterial flora and treatment enigma. [2005.05]

Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. [2005.06]

A novel foam vehicle for delivery of topical corticosteroids. [2005.07]

Staphylococcal skin infections in children: rational drug therapy recommendations. [2005]

Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. [2005.04]

Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy. [2007.02]

Progressive macular hypomelanosis: an overview. [2007]

[Anti-microbial therapies for acne vulgaris: anti-inflammatory actions of anti-microbial drugs and their effectiveness] [2007.03.01]

Evidence-based recommendations for antimicrobial nasal washes in chronic rhinosinusitis. [2006.01]

Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab. [2007.01.27]

An elderly lady with sudden blindness and a sore foot. [2006.02]

Utilizing combination therapy for ethnic skin. [2007.07]

The impact and importance of resistance. [2007.07]

Diagnosis and anti-infective therapy of periodontitis. [2007.08]

Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. [2007.11]

Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. [2008.01]

Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence. [2008.02]

Acneiform eruption induced by cetuximab. [2007]

Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris - A pilot study. [2008.07]

Comparative irritation potential of two combination acne products: a randomized controlled, subject- and evaluator-blind, comparative study in healthy volunteers. [2008]

Novel vesicular and particulate drug delivery systems for topical treatment of acne. [2008.06]

[Adverse cutaneous reactions to erlotinib] [2008.01]

The effect of vehicle formulation on acne medication tolerability. [2008.10]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017